NWBI Heads Into Q3 Print With Bears Retreating
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
NWBI reports Q3 results on October 27 against a backdrop of easing short pressure and options markets tilting modestly toward the bull side.
Short sellers have been trimming exposure heading into the print. Short interest in Northwest Bancshares has fallen roughly 1.4% over the past week to 6.2% of the free float, though the monthly picture tells a more complicated story: shorts are still up about 15% over the past month. The borrow market offers no meaningful signal either way. Cost to borrow has dropped around 18% over the week to just 0.42%, and availability is exceptionally loose at over 1,250% of outstanding short interest, meaning new shorts face no constraint in establishing positions. Borrow pressure is simply not a factor here. The stock itself has had a quiet run-up: up 4.5% on the week and 0.3% on the day to close at $15.53, in line with peers such as HOPE and UBSI, which gained 4.8% and 4.2% respectively over the same period.
Options positioning leans slightly constructive into the print. The put/call ratio has dropped to 0.64, below its 20-day average of 0.76, putting it about 0.7 standard deviations below the mean. That is a mild tilt toward calls rather than a strong conviction read, and the PCR has ranged widely over the past year from 0.07 to 3.65, so the current level sits firmly in neutral territory. The shift is nonetheless a contrast to the more defensive posture options buyers held through most of October, when the PCR was running close to 0.90.
The analyst community has been incrementally more optimistic since the last quarterly print. Following the July earnings beat, which sent the stock up 3.1% on the day and 3.9% over the following week, Truist raised its target to $18 and Keefe, Bruyette and Woods lifted to $16, both maintaining their existing ratings. DA Davidson also moved its target up to $17. The consensus mean price target now sits at $16.29, about 5% above the current price of $15.53, leaving limited but positive implied upside. The bull case rests on steady loan growth, stable net interest income, and the integration of the Penns Woods acquisition. Bears point to valuation risk: a P/E of around 10.7 and a price-to-book of 1.1 are not demanding for a regional bank, but some analysts flag that recent EPS upgrades may have pulled the stock ahead of fundamental delivery.
ORTEX's FDIC call report data, published by the Federal Deposit Insurance Corporation, adds balance-sheet context. The FDIC series shows that Northwest Bancshares' total assets have risen for seven consecutive quarters, reaching $17.2 billion, while net loans and leases have grown for six straight quarters to $13.1 billion. The FDIC lead dataset has not yet been tested against the company's reported figures, so these series cannot be described as leading indicators, but the streak of asset and loan growth is a concrete data point the print will either extend or break.
The Q3 report is therefore a test of whether the momentum in the balance sheet translates into the margin and fee-income delivery that analysts upgraded their targets to reflect after the July beat.
Stocks in this article
See the live data behind this article on ORTEX.
Open NWBI on ORTEX →How this article was generated
- Generated
- 27 Oct 2026, 04:26
- Data as of
- 27 Oct 2026, 04:02
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.